文献速递泌尿男性生殖肿瘤

兄弟间非低危前列腺癌的一致性研究

Concordance of Non-Low-Risk Disease Among Pairs of Brothers With Prostate Cancer.
PubMed 文献 · J Clin Oncol · 2018-04-13

基于瑞典前列腺癌数据库4262对兄弟,分析非低危前列腺癌在同卵双胎、异卵双胎、全兄弟和半兄弟间的一致性。调整年龄和诊断年份后,同卵双胎同患非低危癌的OR为3.82(95%CI 0.99-16.72),全兄弟为1.21(95%CI 1.04-1.39)。提示非低危前列腺癌具有遗传模式,兄弟患病时自身侵袭性癌风险临床相关增加。

要点

  • 同卵双胎均患非低危前列腺癌的OR为3.82(95%CI 0.99-16.72)。
  • 全兄弟均患非低危前列腺癌的调整OR为1.21(95%CI 1.04-1.39)。
  • 兄弟患非低危前列腺癌者,自身侵袭性癌风险临床相关增加。

核心结论

  • 非低危前列腺癌具有遗传模式,提示共享遗传因素,同卵双胎一致性最高。
  • 兄弟被诊断非低危前列腺癌的男性,自身发生侵袭性前列腺癌的风险临床相关增加。

研究设计与样本

  • 基于瑞典前列腺癌数据库的兄弟对研究,共纳入4262对患前列腺癌的兄弟。
  • 癌症分为低危(Gleason评分≤6;临床分期T1-2,Nx/N0,Mx/M0;PSA≤10 ng/mL)或非低危。
  • 采用逻辑回归计算不同亲缘类型(同卵双胎、异卵双胎、全兄弟、半兄弟)非低危癌一致性的OR,调整年龄和诊断年份。

主要发现

  • 同卵双胎均患非低危前列腺癌的调整OR为3.82(95%CI 0.99-16.72)。
  • 全兄弟均患非低危前列腺癌的调整OR为1.21(95%CI 1.04-1.39)。
  • 限制于双方均在4年内诊断的兄弟时,结果相似。

关键数值与推荐

  • 低危定义:Gleason评分≤6;临床分期T1-2,Nx/N0,Mx/M0;PSA≤10 ng/mL。

临床怎么用

  • 兄弟患非低危前列腺癌的男性,应视为侵袭性前列腺癌风险临床相关增加的人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Purpose Prostate cancer among first-degree relatives is a strong risk factor for diagnosis of prostate cancer, and the contribution of heritable factors in prostate cancer etiology is high. We investigated how the concordance of non-low-risk prostate cancer among brothers is affected by their genetic relation. Methods We identified 4,262 pairs of brothers with prostate cancer in the Prostate Cancer Database Sweden. Their cancers were categorized as low risk (Gleason score ≤ 6; clinical stage T1-2, Nx/N0, Mx/M0; and prostate-specific antigen ≤ 10 ng/mL) or non-low risk. The odds ratio (OR) for concordance of non-low-risk cancer was calculated with logistic regression for the different types of fraternity (monozygotic twins, dizygotic twins, full brothers, and half-brothers) Results Among monozygotic twins who both were diagnosed with prostate cancer, the OR for both brothers being in the non-low-risk category was 3.82 (95% CI, 0.99 to 16.72) after adjusting for age and year of diagnosis. Among full brothers, the corresponding adjusted OR was 1.21 (95% CI, 1.04 to 1.39). When the analysis was restricted to brothers who both were diagnosed within 4 years, the results were similar. Conclusion Non-low-risk prostate cancer has a heritable pattern suggesting shared genetic factors, with the highest concordance among monozygotic twins. Our results suggest that a man whose brother has been diagnosed with a non-low-risk prostate cancer is at a clinically relevant increased risk of developing an aggressive prostate cancer himself.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Jansson F, Drevin L, Frisell T, et al. Concordance of Non-Low-Risk Disease Among Pairs of Brothers With Prostate Cancer. J Clin Oncol. 2018. PMID: 29652556. doi:10.1200/JCO.2017.76.6907

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。